Literature DB >> 1849808

Detection of endogenous cytokines in sera or in lymph nodes obtained from patients with sarcoidosis.

M Asano1, T Minagawa, M Ohmichi, Y Hiraga.   

Abstract

To investigate the possible role of endogenous cytokines in the immunopathogenesis of sarcoidosis, a study of cytokines in lymph nodes obtained from patients with active pulmonary sarcoidosis was carried out using immunoperoxidase staining and radioimmunoassays (RIA). Cells stained for interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha), which appeared to be CD3+ cells and CD14+ cells, respectively, were seen scattered around granulomas. In contrast, cells positive for interleukin-1 beta (IL-1 beta) were located in CD11c+ cells within granulomas. Lymph nodes of patients with sarcoidosis contained significantly higher amounts of IFN-gamma, TNF-alpha and IL-1 beta than control lymph nodes. The levels of IFN-gamma and TNF-alpha in extracts of lymph nodes were correlated with the histological status of the granulomas. IFN-gamma was detected in all stages, while the highest level of TNF-alpha was obtained from lymph nodes containing many active granulomas. The level of serum IFN-gamma was always lower than in lymph node extract and correlated significantly with either serum angiotensin-converting enzyme or serum lysozyme. Patients with positive gallium-67 uptake or bilateral hilar lymphadenopathy had high levels of either serum IFN-gamma or lysozyme. These results suggest that quantitative analyses of IFN-gamma and TNF-alpha in sera and lymph nodes may serve to elucidate the pathophysiology of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849808      PMCID: PMC1535346          DOI: 10.1111/j.1365-2249.1991.tb08129.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Immunoreactivity for IL-1 beta and TNF alpha in human lymphoid and nonlymphoid tissues.

Authors:  L P Ruco; A Stoppacciaro; D Pomponi; D Boraschi; A Santoni; A Tagliabue; S Uccini; C D Baroni
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

2.  Immune interferon is a growth factor for human lung fibroblasts.

Authors:  G W Hunninghake; C Hemken; M Brady; M Monick
Journal:  Am Rev Respir Dis       Date:  1986-11

3.  Interferon and growth factor activity for human lung fibroblasts. Release from bronchoalveolar cells from patients with active sarcoidosis.

Authors:  P L Moseley; C Hemken; M Monick; K Nugent; G W Hunninghake
Journal:  Chest       Date:  1986-05       Impact factor: 9.410

4.  Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis. Immunohistologic evidence that inflammatory macrophages express IL-2 receptors.

Authors:  W W Hancock; L Kobzik; A J Colby; C J O'Hara; A G Cooper; J J Godleski
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

5.  Analysis of CD4-positive T cell subpopulation in sarcoidosis.

Authors:  R Gerli; S Darwish; L Broccucci; V Minotti; F Spinozzi; C Cernetti; A Bertotto; P Rambotti
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

Review 6.  Sarcoidosis.

Authors:  D N Mitchell; J G Scadding
Journal:  Am Rev Respir Dis       Date:  1974-12

7.  Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas.

Authors:  E Silverstein; L P Pertschuk; J Friedland
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

8.  Evaluation of alveolar macrophages in normals and individuals with active pulmonary sarcoidosis for the spontaneous expression of the interleukin-1 beta gene.

Authors:  M D Wewers; C Saltini; S Sellers; M J Tocci; E K Bayne; J A Schmidt; R G Crystal
Journal:  Cell Immunol       Date:  1987-07       Impact factor: 4.868

9.  The macrophage in sarcoid granuloma formation.

Authors:  M A Spiteri; L W Poulter; D Geraint-James
Journal:  Sarcoidosis       Date:  1989-10

10.  Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations.

Authors:  G Semenzato; C Agostini; R Zambello; L Trentin; M Chilosi; M R Angi; E Ossi; A Cipriani; G Pizzolo
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

View more
  11 in total

1.  Reciprocal action of interferon-gamma and interleukin-4 promotes granulomatous inflammation induced by Rhodococcus aurantiacus in mice.

Authors:  M Asano; M Kohanawa; T Minagawa; A Nakane
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

2.  Whither sarcoidosis?

Authors:  O P Sharma
Journal:  West J Med       Date:  1995-06

3.  Increased CD11/CD18 expression on peripheral blood leucocytes of patients with sarcoidosis.

Authors:  Z Shakoor; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

4.  Clonal analysis of lung and blood T cells in patients with sarcoidosis.

Authors:  M J Garlepp; A H Rose; J E Dench; B W Robinson
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

5.  Circulating adhesion molecules in sarcoidosis.

Authors:  A S Hamblin; Z Shakoor; P Kapahi; D Haskard
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

6.  Presence of mRNA for interferon-gamma (IFN-gamma) in blood mononuclear cells is associated with an active stage I sarcoidosis.

Authors:  C Swider; A Laba; A Moniewska; J Gerdes; H D Flad; A Lange
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

7.  Endogenous gamma interferon is essential in granuloma formation induced by glycolipid-containing mycolic acid in mice.

Authors:  M Asano; A Nakane; T Minagawa
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

8.  Soluble intercellular adhesion molecule-1 (ICAM-1) in sera and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.

Authors:  N Shijubo; K Imai; K Shigehara; Y Honda; H Koba; M Tsujisaki; Y Hinoda; A Yachi; M Ohmichi; Y Hiraga
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

9.  Differential inflammatory microRNA and cytokine expression in pulmonary sarcoidosis.

Authors:  Agnieszka Jazwa; Lukasz Kasper; Maciej Bak; Mateusz Sobczak; Krzysztof Szade; Alicja Jozkowicz; Krzysztof Sladek; Jozef Dulak
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-11-01       Impact factor: 4.291

10.  Matrix Metalloproteinase-12 Is Required for Granuloma Progression.

Authors:  Arjun Mohan; Nicole Neequaye; Anagha Malur; Eman Soliman; Matthew McPeek; Nancy Leffler; David Ogburn; Debra A Tokarz; Warren Knudson; Sina A Gharib; Lynn M Schnapp; Barbara P Barna; Mary Jane Thomassen
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.